BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21732180)

  • 21. Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.
    Valentine LE; Loffredo JT; Bean AT; León EJ; MacNair CE; Beal DR; Piaskowski SM; Klimentidis YC; Lank SM; Wiseman RW; Weinfurter JT; May GE; Rakasz EG; Wilson NA; Friedrich TC; O'Connor DH; Allison DB; Watkins DI
    J Virol; 2009 Nov; 83(22):11514-27. PubMed ID: 19726517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.
    Wu Y; Gao F; Liu J; Qi J; Gostick E; Price DA; Gao GF
    J Immunol; 2011 Dec; 187(12):6382-92. PubMed ID: 22084443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02.
    Robinson S; Charini WA; Newberg MH; Kuroda MJ; Lord CI; Letvin NL
    J Virol; 2001 Nov; 75(21):10179-86. PubMed ID: 11581386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
    Donahoe SM; Moretto WJ; Samuel RV; Metzner KJ; Marx PA; Hanke T; Connor RI; Nixon DF
    Virology; 2000 Jul; 272(2):347-56. PubMed ID: 10873778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Letvin NL
    J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes.
    Kaizu M; Borchardt GJ; Glidden CE; Fisk DL; Loffredo JT; Watkins DI; Rehrauer WM
    Immunogenetics; 2007 Sep; 59(9):693-703. PubMed ID: 17641886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.
    Newberg MH; McEvers KJ; Gorgone DA; Lifton MA; Baumeister SH; Veazey RS; Schmitz JE; Letvin NL
    J Immunol; 2006 Jan; 176(1):319-28. PubMed ID: 16365424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.
    Maness NJ; Yant LJ; Chung C; Loffredo JT; Friedrich TC; Piaskowski SM; Furlott J; May GE; Soma T; León EJ; Wilson NA; Piontkivska H; Hughes AL; Sidney J; Sette A; Watkins DI
    J Virol; 2008 Jun; 82(11):5245-54. PubMed ID: 18385251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus.
    Weinfurter JT; May GE; Soma T; Hessell AJ; León EJ; Macnair CE; Piaskowski SM; Weisgrau K; Furlott J; Maness NJ; Reed J; Wilson NA; Rakasz EG; Burton DR; Friedrich TC
    J Virol; 2011 Jan; 85(1):530-41. PubMed ID: 20962091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of a T cell receptor of potent CD8
    Ishii H; Matsuoka S; Ikeda N; Kurihara K; Ueno T; Takiguchi M; Naruse TK; Kimura A; Yokoyama M; Sato H; Matano T
    Biochem Biophys Res Commun; 2020 Jan; 521(4):894-899. PubMed ID: 31711644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding Characteristics.
    de Groot NG; Heijmans CMC; de Ru AH; Janssen GMC; Drijfhout JW; Otting N; Vangenot C; Doxiadis GGM; Koning F; van Veelen PA; Bontrop RE
    J Immunol; 2017 Nov; 199(10):3679-3690. PubMed ID: 29021373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.
    Li J; Srivastava T; Rawal R; Manuel E; Isbell D; Tsark W; La Rosa C; Wang Z; Li Z; Barry PA; Hagen KD; Longmate J; Diamond DJ
    Virology; 2009 Apr; 387(1):16-28. PubMed ID: 19249807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.
    Giraldo-Vela JP; Rudersdorf R; Chung C; Qi Y; Wallace LT; Bimber B; Borchardt GJ; Fisk DL; Glidden CE; Loffredo JT; Piaskowski SM; Furlott JR; Morales-Martinez JP; Wilson NA; Rehrauer WM; Lifson JD; Carrington M; Watkins DI
    J Virol; 2008 Jan; 82(2):859-70. PubMed ID: 17989178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.
    Mühl T; Krawczak M; Ten Haaft P; Hunsmann G; Sauermann U
    J Immunol; 2002 Sep; 169(6):3438-46. PubMed ID: 12218167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SIV Nef CD8(+) T cell epitopes restricted by a MHC class I haplotype associated with lower viral loads in a macaque AIDS model.
    Nomura T; Yamamoto H; Takahashi N; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2014 Jul; 450(2):942-7. PubMed ID: 24971540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B*27 and Mamu-B*08: Two MHC Class I Alleles Associated with Elite Control of HIV/SIV Infection.
    Marcilla M; Alvarez I; Ramos-Fernández A; Lombardía M; Paradela A; Albar JP
    J Proteome Res; 2016 Mar; 15(3):1059-69. PubMed ID: 26811146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeys.
    Osuna CE; Gonzalez AM; Chang HH; Hung AS; Ehlinger E; Anasti K; Alam SM; Letvin NL
    PLoS Pathog; 2014 Apr; 10(4):e1004069. PubMed ID: 24743648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.